Is there an association between dipeptidyl peptidase-4 inhibitors and autoimmune disease? A population-based study

In conclusion, this population-based study demonstrates an assoc iation of DPP4i intake with three autoimmune and inflammatory diseases noted to be part of a distinct autoimmune cluster that includes multiple sclerosis, psoriasis, thyroiditis, bullous pemphigoid, and inflammatory bowel disease. Experimental studies are required to define the role of DPP4i in this autoimmune cluster.

http://link.springer.com/10.1007/s12026-018-9005-8

Source: Immunologic Research - May 31, 2018 Category: Allergy & Immunology Source Type: research